|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Epzicom (Abacavir / Lamivudine). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (69)
Cases resulting in a serious event (59)
Cases resulting in life threatening events (13)
Cases resulting in hospitalization (31)
Cases resulting in disability (1)
Cases resulting in other serious reactions (29)
Below is a sample of reports where side effects / adverse reactions may be related to Epzicom (Abacavir / Lamivudine). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in 42 year old male receiving Epzicom (Abacavir / Lamivudine)
Reported by a physician from Japan on 2007-10-31
Patient: 42 year old male
Adverse reactions / side effects: Hepatic Function Abnormal
Suspect drug(s):
Epzicom (Abacavir / Lamivudine)
Other drugs received by patient: Epivir; Retrovir; Norvir; Reyataz; Reyataz; Viread; Zithromax; Baktar; Hokunalin; Uniphyl
Adverse event in 42 year old male receiving Epzicom (Abacavir / Lamivudine)
Reported by a physician from Japan on 2007-10-29
Patient: 42 year old male
Adverse reactions / side effects: Hepatic Function Abnormal
Suspect drug(s):
Epzicom (Abacavir / Lamivudine)
Other drugs received by patient: Epivir; Retrovir; Norvir; Reyataz; Reyataz; Viread; Zithromax; Baktar; Hokunalin; Uniphyl
Adverse event in 53 year old male receiving Epzicom (Abacavir / Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: 53 year old male
Adverse reactions / side effects: Jaundice, Hepatitis B, Liver Disorder, Hepatitis Fulminant, Ascites
Adverse event resulted in: hospitalization
Suspect drug(s):
Efavirenz
Administration route: Oral
Indication: HIV Infection
Start date: 2005-10-03
End date: 2006-09-25
Videx EC
Administration route: Oral
Indication: HIV Infection
Start date: 2005-10-03
End date: 2006-09-25
Retrovir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-10-03
End date: 2006-09-25
Kaletra
Dosage: 4tablet/daily started from 27-oct-2006
Administration route: Oral
Indication: HIV Infection
Start date: 2006-09-26
End date: 2006-09-28
Epzicom
Dosage: 1 dosage form= 1 tablet.
Administration route: Oral
Indication: HIV Infection
Start date: 2006-09-26
End date: 2006-09-28
Other drugs received by patient: Urso 250; Cinal S; Cellulase; Lipase; Lendormin; Ursodiol
Adverse event in 32 year old female receiving Epzicom (Abacavir / Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-10-23
Patient: 32 year old female
Adverse reactions / side effects: Dyspnoea, Rash, Pyrexia
Suspect drug(s):
Epzicom (Abacavir / Lamivudine)
Other drugs received by patient: Kaletra; Effexor; Lisinopril; Cogentin; Depakote; Percocet
Adverse event in 23 year old female receiving Epzicom (Abacavir / Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-19
Patient: 23 year old female
Adverse reactions / side effects: Complication of Pregnancy
Suspect drug(s):
Invirase
Dosage: total daily dose: 600mg/300mg
Administration route: Oral
Indication: Acute HIV Infection
Start date: 2007-10-04
Epzicom
Administration route: Oral
Indication: Acute HIV Infection
Start date: 2007-10-04
Adverse event in 46 year old male receiving Epzicom (Abacavir / Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-10-18
Patient: 46 year old male
Adverse reactions / side effects: Nausea, Tachycardia, Drug Hypersensitivity, Hypotension, Pyrexia, Rash Pruritic, Myalgia, Malaise, Fatigue, Diarrhoea, Oliguria
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Epzicom
Administration route: Oral
Indication: HIV Infection
Start date: 2007-01-17
End date: 2007-10-09
Norvir
Dosage: 100mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2007-01-17
End date: 2007-10-09
Bactrim
Start date: 2007-10-08
End date: 2007-10-09
Other drugs received by patient: Reyataz; Wellbutrin; Valtrex; Trazodone HCL; Coenzyme Q10; Vitamin B Complex CAP; Fish OIL; Multi-Vitamin; Aspirin; Zantac; Neurontin; Vancomycin; Ceftriaxone; Vancomycin; Ciprofloxacin; Bactrim
Adverse event in female receiving Epzicom (Abacavir / Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-10-10
Patient: female, weighing 0.7 kg (1.5 pounds)
Adverse reactions / side effects: Congenital Hand Malformation, Drug Exposure During Pregnancy, Premature Baby, Amniotic Cavity Disorder
Suspect drug(s):
Epzicom
Indication: Drug USE FOR Unknown Indication
Start date: 2006-10-01
Lotrel
Indication: Drug USE FOR Unknown Indication
End date: 2007-06-19
Other drugs received by patient: Viramune; Procardia XL
Adverse event in female receiving Epzicom (Abacavir / Lamivudine)
Reported by a physician from United States on 2007-10-10
Patient: female, weighing 1.0 kg (2.2 pounds)
Adverse reactions / side effects: Small FOR Dates Baby, Congenital Hand Malformation, Premature Baby
Suspect drug(s):
Viramune
Indication: HIV Infection
Start date: 2006-10-01
Epzicom
Indication: HIV Infection
Start date: 2006-10-01
Lotrel
End date: 2007-06-19
Procardia XL
Start date: 2007-06-19
Adverse event in receiving Epzicom (Abacavir / Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-09
Patient:
Adverse reactions / side effects: Abortion Spontaneous
Suspect drug(s):
Viracept
Dosage: daily dose:2500meq
Administration route: Oral
Start date: 2007-05-30
End date: 2007-06-18
Trizivir
Dosage: text:600/600/300
Administration route: Oral
Start date: 2007-05-30
End date: 2007-06-18
Efavirenz
Dosage: daily dose:600mg
Administration route: Oral
Efavirenz
Dosage: text:600/300 mg
Administration route: Oral
Epzicom
Dosage: text:600/300 mg
Administration route: Oral
Epzicom
Dosage: text:600/300 mg
Administration route: Oral
Adverse event in 39 year old female receiving Epzicom (Abacavir / Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-05
Patient: 39 year old female
Adverse reactions / side effects: Drug Exposure During Pregnancy, Abortion Spontaneous
Suspect drug(s):
Epzicom
Dosage: 1tab per day
Administration route: Oral
Indication: HIV Infection
End date: 2007-05-20
Trizivir
Dosage: 2tab per day
Administration route: Oral
Indication: HIV Infection
Start date: 2007-05-30
End date: 2007-06-18
Efavirenz
Dosage: 600mg per day
Administration route: Oral
Indication: HIV Infection
End date: 2007-05-20
Nelfinavir
Dosage: 2500mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2007-05-30
End date: 2007-06-18
Adverse event in 55 year old male receiving Epzicom (Abacavir / Lamivudine)
Reported by a physician from United States on 2007-10-03
Patient: 55 year old male, weighing 82.1 kg (180.6 pounds)
Adverse reactions / side effects: Miller Fisher Syndrome, Pneumonitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Fuzeon
Start date: 2007-02-21
End date: 2007-08-01
Epzicom
Administration route: Oral
Start date: 2007-02-21
End date: 2007-08-01
Epzicom
Administration route: Oral
Start date: 2007-08-24
Unspecified Drug
Dosage: reported as raltegravir/ mk-0518
Administration route: Oral
Start date: 2007-02-21
End date: 2007-08-01
Unspecified Drug
Administration route: Oral
Start date: 2007-08-24
Unspecified Drug
Dosage: reported as davuravir/prezista
Administration route: Oral
Start date: 2007-02-21
End date: 2007-08-01
Unspecified Drug
Administration route: Oral
Start date: 2007-08-24
Adverse event in male receiving Epzicom (Abacavir / Lamivudine)
Reported by a individual with unspecified qualification from United States on 2007-10-01
Patient: male, weighing 3.0 kg (6.6 pounds)
Adverse reactions / side effects: Drug Exposure During Pregnancy, Congenital Anomaly
Suspect drug(s):
Kaletra
Indication: Drug Exposure During Pregnancy
Epzicom
Indication: Drug Exposure During Pregnancy
Lamivudine + Zidovudine
Indication: Drug Exposure During Pregnancy
Nelfinavir Mesilate
Indication: Drug Exposure During Pregnancy
Adverse event in female receiving Epzicom (Abacavir / Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-07-30
Patient: female
Adverse reactions / side effects: Drug Hypersensitivity, Pulmonary Oedema
Adverse event resulted in: hospitalization
Suspect drug(s):
Epzicom (Abacavir / Lamivudine)
Other drugs received by patient: Unknown
Adverse event in male receiving Epzicom (Abacavir / Lamivudine)
Reported by a physician from United States on 2007-07-06
Patient: male, weighing 56.0 kg (123.2 pounds)
Adverse reactions / side effects: Drug Hypersensitivity
Suspect drug(s):
Etravirine
Administration route: Oral
Indication: HIV Infection
Epzicom
Administration route: Oral
Indication: HIV Infection
Other drugs received by patient: MK-0518; Norvir; Prezista; Combivir; Kaletra; Mepron; Acyclovir; Nystatin; Prednisone TAB; Pepcid
Adverse event in female receiving Epzicom (Abacavir / Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-06-29
Patient: female
Adverse reactions / side effects: Dyspnoea, Syncope, Feeling Hot, Dizziness
Suspect drug(s):
Epzicom
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Reyataz
Indication: Drug USE FOR Unknown Indication
Adverse event in female receiving Epzicom (Abacavir / Lamivudine)
Reported by a physician from United States on 2007-06-27
Patient: female, weighing 79.4 kg (174.6 pounds)
Adverse reactions / side effects: Hypersensitivity
Adverse event resulted in: hospitalization
Suspect drug(s):
Prezista
Administration route: Oral
Prezista
Dosage: temporary stop
Administration route: Oral
Indication: HIV Infection
Tmc125
Dosage: temporary stop
Administration route: Oral
Indication: HIV Infection
Epzicom
Administration route: Oral
Indication: HIV Infection
Ritonavir
Indication: HIV Infection
Other drugs received by patient: Valtrex; Glucophage; Metoprolol Tartrate; Clarinex; Bactrim; Vasotec
Adverse event in 18 year old male receiving Epzicom (Abacavir / Lamivudine)
Reported by a individual with unspecified qualification from United States on 2007-06-21
Patient: 18 year old male
Adverse reactions / side effects: Skin Exfoliation, Hypotension, Hyperglycaemia, Drug Hypersensitivity, Hyponatraemia, Headache, Hypoaesthesia, Treatment Noncompliance, Hypokalaemia, Paraesthesia, Scleral Discolouration, Fatigue, Sepsis, Heart Rate Increased, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Epzicom (Abacavir / Lamivudine)
Adverse event in 63 year old male receiving Epzicom (Abacavir / Lamivudine)
Reported by a pharmacist from Japan on 2007-06-18
Patient: 63 year old male, weighing 48.0 kg (105.6 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Jaundice, Pyrexia, Liver Disorder, Malaise, Generalised Erythema, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Blood Alkaline Phosphatase Increased, Nausea, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Drug Hypersensitivity, Rash, Aspartate Aminotransferase Increased, Anorexia, Bilirubin Conjugated Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Epzicom
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2007-04-11
End date: 2007-04-16
Kaletra
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2007-04-11
End date: 2007-04-16
Other drugs received by patient: Pariet; Zithromac; Baktar; Baktar; Miya BM; Spiriva; Antiemetic; Unknown Drug
Adverse event in 35 year old female receiving Epzicom (Abacavir / Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-06-11
Patient: 35 year old female
Adverse reactions / side effects: Trisomy 21, Alpha 1 Foetoprotein Abnormal
Suspect drug(s):
Invirase
Indication: Drug USE FOR Unknown Indication
Start date: 2006-04-01
Epzicom
Indication: Drug USE FOR Unknown Indication
End date: 2005-12-25
Combivir
Indication: Drug USE FOR Unknown Indication
Start date: 2006-04-11
Ritonavir
Indication: Drug USE FOR Unknown Indication
Start date: 2006-04-11
Viramune
Indication: Drug USE FOR Unknown Indication
End date: 2005-12-05
Adverse event in male receiving Epzicom (Abacavir / Lamivudine)
Reported by a individual with unspecified qualification from United States on 2007-05-31
Patient: male, weighing 77.4 kg (170.3 pounds)
Adverse reactions / side effects: Hypersensitivity
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Emtricitabine / Tenofovir Disoproxil Fumarate
Administration route: Oral
Indication: HIV Infection
Start date: 2006-12-14
End date: 2006-12-28
Sustiva
Administration route: Oral
Indication: HIV Infection
Start date: 2006-12-14
End date: 2006-12-23
Epzicom
Administration route: Oral
Indication: HIV Infection
Start date: 2006-12-14
End date: 2006-12-28
Adverse event in female receiving Epzicom (Abacavir / Lamivudine)
Reported by a pharmacist from United States on 2007-05-23
Patient: female
Adverse reactions / side effects: Dyspnoea, Drug Hypersensitivity
Adverse event resulted in: hospitalization
Suspect drug(s):
Epzicom (Abacavir / Lamivudine)
Other drugs received by patient: Viracept
Adverse event in female receiving Epzicom (Abacavir / Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-18
Patient: female, weighing 3.0 kg (6.6 pounds)
Adverse reactions / side effects: Normal Newborn, Drug Exposure During Pregnancy, Normal Delivery
Suspect drug(s):
Epzicom
Dosage: 1tab per day
Indication: HIV Infection
Reyataz
Dosage: 300mg per day
Indication: HIV Infection
AZT
Indication: HIV Infection
Start date: 2006-09-20
End date: 2006-09-20
Other drugs received by patient: Norvir
Adverse event in 23 year old male receiving Epzicom (Abacavir / Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-05-18
Patient: 23 year old male, weighing 76.8 kg (169.0 pounds)
Adverse reactions / side effects: Drug Hypersensitivity, Chest Pain, Rash, Pyrexia
Suspect drug(s):
Epzicom (Abacavir / Lamivudine)
Other drugs received by patient: Septrin
Adverse event in male receiving Epzicom (Abacavir / Lamivudine)
Reported by a physician from United States on 2007-05-18
Patient: male, weighing 56.0 kg (123.2 pounds)
Adverse reactions / side effects: Vomiting, Hypersensitivity, Fatigue, Nausea
Suspect drug(s):
Etravirine
Administration route: Oral
Indication: HIV Infection
Epzicom
Administration route: Oral
Indication: HIV Infection
Prezista
Administration route: Oral
Indication: HIV Infection
Norvir
Administration route: Oral
Indication: HIV Infection
MK-0518
Administration route: Oral
Indication: HIV Infection
Other drugs received by patient: Combivir; Kaletra; Mepron; Acyclovir; Nystatin; Prednisone TAB; Pepcid
Adverse event in 33 year old female receiving Epzicom (Abacavir / Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-05-16
Patient: 33 year old female
Adverse reactions / side effects: Alopecia
Suspect drug(s):
Epzicom (Abacavir / Lamivudine)
Other drugs received by patient: Azithromycin; Levaquin; Prednisone TAB; Zoloft; Cymbalta; Gabapentin; Norvir; Reyataz; Tenofovir
|
